IRWD: Ironwood Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 304.05
Enterprise Value ($M) 814.66
Book Value ($M) -311.33
Book Value / Share -1.95
Price / Book -0.98
NCAV ($M) -522.25
NCAV / Share -3.26
Price / NCAV -0.58

Profitability (mra)
Return on Invested Capital (ROIC) -0.01
Return on Assets (ROA) -0.01
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 3.62
Current Ratio 3.62

Balance Sheet (mrq) ($M)
Current Assets 178.60
Assets 389.52
Liabilities 700.85
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Armistice Capital, Llc
02-05 13G State Street Corp
01-31 13G/A Vanguard Group Inc
11-13 13G Renaissance Technologies Llc
11-08 13G/A BlackRock, Inc. 14.30 0.00
2024-02-09 13G/A Lsv Asset Management 4.35 -14.29

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-21 285,662 1,411,303 20.24
2025-02-20 181,931 1,227,617 14.82
2025-02-19 324,304 1,581,169 20.51
2025-02-18 730,917 3,313,342 22.06

(click for more detail)

Similar Companies
IOBT – IO Biotech, Inc. IONS – Ionis Pharmaceuticals, Inc.
IPSC – Century Therapeutics, Inc. ITCI – Intra-Cellular Therapies, Inc.
JAZZ – Jazz Pharmaceuticals plc


Financial data and stock pages provided by
Fintel.io